ATC code L

ATC code L is a section of the Anatomical Therapeutic Chemical Classification System (ATC), a system used for the classification of drugs and other medical products. The ATC system is controlled by the World Health Organization (WHO) and is used globally to ensure the consistent classification of medications.

Subgroups

The ATC code L is divided into the following subgroups:

L01 Antineoplastic agents

• L01A Alkylating agents
• L01B Antimetabolites
• L01C Plant alkaloids and other natural products
• L01D Cytotoxic antibiotics and related substances
• L01E Protein kinase inhibitors
• L01X Other antineoplastic agents

L02 Endocrine therapy

• L02A Hormones and related agents
• L02B Hormone antagonists and related agents

L03 Immunostimulants

• L03A Immunostimulants

L04 Immunosuppressants

• L04A Immunosuppressants

Usage

The ATC code L is primarily used in the field of oncology and immunology. It includes drugs that are used to treat various types of cancer and conditions that require modulation of the immune system.

Importance

The classification of drugs under ATC code L is crucial for the development of treatment protocols and for the research and development of new therapeutic agents. It helps healthcare professionals to identify and prescribe the appropriate medication for specific conditions.

See also

• ATC code
• Anatomical Therapeutic Chemical Classification System
• World Health Organization

External links

ATC codes
L Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L02 Endocrine therapy
L03 Immunostimulants
L04 Immunosuppressants
A B C D G H QI J L M N P R S V (Hover over links to see titles)

   This article is a medical stub. You can help WikiMD by expanding it!